Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Cells|September 13, 2025
Development, Functional Characterization, and Matrix Effectors Dynamics in 3D Spheroids of Triple-Negative Breast Cancer CellsNikolaos E Koletsis, Sylvia Mangani, Marco Franchi, et al.The FEBS Journal|March 12, 2020
Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signalingKonstantina Karamanou, Marco Franchi, Maurizio Onisto, et al.Journal of Clinical Medicine|February 10, 2019
Collagen Fiber Array of Peritumoral Stroma Influences Epithelial-to-Mesenchymal Transition and Invasive Potential of Mammary Cancer CellsMarco Franchi, Valentina Masola, Gloria Bellin, et al.Matrix Biology Plus|February 5, 2021
Long filopodia and tunneling nanotubes define new phenotypes of breast cancer cells in 3D culturesMarco Franchi, Zoi Piperigkou, Eirini Riti, et al.Journal of Medicinal Chemistry|February 20, 2004
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamidesDaniela Vullo, Marco Franchi, Enzo Gallori, et al.Micron (Oxford, England : 1993)|December 3, 2008
Structure relates to elastic recoil and functional role in quadriceps tendon and patellar ligamentMarco Franchi, Marilisa Quaranta, Maria Macciocca, et al.Frontiers in Oncology|August 15, 2022
Heparanase regulates EMT and cancer stem cell properties in prostate tumorsValentina Masola, Marco Franchi, Gianluigi Zaza, et al.The FEBS Journal|February 7, 2019
Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancerAnastasia G Tavianatou, Ilaria Caon, Marco Franchi, et al.Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Carbonic anhydrase inhibitors: inhibition of human and murine mitochondrial isozymes V with anionsMarco Franchi, Daniela Vullo, Enzo Gallori, et al.Frontiers in Oncology|June 20, 2022
<i>ESR2</i> Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis <i>In Vivo</i>Zoi Piperigkou, Anastasios Koutsandreas, Marco Franchi, et al.Pageof 6